Investor urges Dr. Martens to explore potential sale
A member of Marathon Partners, one of the 30 largest investors in Dr. Martens with approximately 5 million shares, is…
strategic review
-
-
Renewcell’s board explores funding alternatives amid sales flux
Renewcell explained its decision to conduct a strategic review follows lower-than-expected sales volumes to fibre producers in its third quarter…
-
Signal: Is Champion the sacrificial lamb in HanesBrands quest for recovery?
In the wake of a comprehensive strategic review prompted by a year of lacklustre performance attributed to substantial debt, US…
